Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating IMGN632 as a monotherapy or in combination with venetoclax and/or azaci…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
Observational real-world study of adult acute myeloid leukemia patients treated with new drugs; currently recruiting.
-
CLINICAL_TRIALS other · 2025-08-13Clinical Trial Update: A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia [NA]
A clinical trial compares allogeneic hematopoietic cell transplantation with the best available standard-of-care therapy for elderly patient…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating iadademstat in combination with azacitidine and venetoclax for newly diagnosed acute myeloid leukemia; recruitment …
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Venetoclax-Decitabine in Untreated Elderly/Unfit AML [NA]
This clinical trial update indicates recruitment for a venetoclax and decitabine regimen in untreated elderly or unfit adults with acute mye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China [Phase 4]
A Phase 4 clinical trial update on oral venetoclax plus subcutaneous azacitidine in newly diagnosed AML patients in China ineligible for int…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]
This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia
This clinical trial update explores whether the platelet-to-white blood cell ratio has prognostic value in patients with Acute Myeloid Leuke…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation [Phase 1]
A Phase 1 dose-escalation study of vorinostat after allogeneic hematopoietic cell transplantation is ongoing.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Muscle Dysfunction in Patients With Haematological Diseases
This clinical trial update describes a study on muscle dysfunction in patients with hematologic diseases, including acute myeloid leukemia, …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Molecular Characterization of Carbapenemase-Producing Enterobacterales [NA]
A clinical trial update describing a planned study at Sohag University on molecular characterization of carbapenemase-producing Enterobacter…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease [Phase 2]
This update describes a Phase 2 clinical trial aiming to optimize AML treatment based on early peripheral blood minimal residual disease sta…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia [Phase 3]
A phase 3 clinical trial is evaluating the effectiveness of medium-dose cytarabine combined with venetoclax as consolidation therapy for eld…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia
This clinical trial update notes that AbbVie is recruiting adults with acute myeloid leukemia in Colombia to assess disease-state changes wh…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Assessment of Geriatric Evaluations Impact on New AML Guidance
A clinical trial sponsored by the Abramson Cancer Center at Penn Medicine is evaluating how geriatric evaluations influence new guidance for…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
This update concerns a Phase 1 study of UCART123v1.2 in relapsed/refractory acute myeloid leukemia, with the trial listed as active but not …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study [Phase 2]
A multicenter Phase 2 clinical trial evaluating an integrated induction-consolidation chemotherapy approach with transplantation for adult a…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymphoblastic Leukemia (SiAML) Score Versus Established Hemostatic Tools
This clinical trial aims to evaluate the clinical utility of the SiAML score versus established hemostatic tools for predicting bleeding and…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 clinical trial evaluating HLA-mismatched unrelated donor bone marrow transplantation with post-transplant cyclophosphamide; the stud…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia [EARLY_Phase 1]
An early-phase 1 study evaluated escalating intravenous doses of INA03 as a single agent in adults with relapsed or refractory acute leukemi…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia [NA]
This entry notes a multicenter platform-type clinical study for refractory/recurrent acute myeloid leukemia in China, currently in the recru…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) [Phase 1]
Phase 1 trial evaluating venetoclax plus azacitidine followed by donor lymphocyte infusion for very high-risk acute myeloid leukemia in pati…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating CD180 CAR-T therapy for relapsed or refractory CD180-positive hematologic malignancies is currently recruiting, i…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
A clinical trial conducted by Assiut University is investigating the frequencies of ABO and Rh blood groups in patients with acute leukemia …
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial update comparing azacitidine plus venetoclax versus stem cell transplant in adults aged 65 and older with acute mye…